Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?

Tongde Wu, Bryan G. Harder, Pak K. Wong, Julie E. Lang, Donna D. Zhang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Mammosphere culture of breast cancer cell lines is an important approach used for enrichment of cancer stem cells (CSCs), which exhibit high tumorigenicity and chemoresistance features. Evidence shows that CSCs maintain lower ROS levels due to elevated expression of ROS-scavenging molecules and antioxidative enzymes, which favors the survival of the CSCs and their chemoresistance. The transcription factor NF-E2-related factor 2 (Nrf2) has emerged as the master regulator of cellular redox homeostasis, by up-regulating antioxidant response element (ARE)-bearing genes products. Although Nrf2 has long-term been regarded as a beneficial defense mechanism, accumulating studies have revealed the "dark side" of Nrf2. High constitutive levels of Nrf2 was observed in many types of tumors and cancer cell lines promoting their resistance to chemotherapeutics. In this study, we report a high expression of Nrf2 and its target genes in mammospheres compared to corresponding adherent cells. In MCF-7 and MDA-MB-231 mammmosphere cells, the Nrf2-mediated cellular protective response is significantly elevated which is associated with increased resistance to taxol and anchorage-independent growth. Brusatol, an inhibitor of the Nrf2 pathway, suppressed the protein level of Nrf2 and its target genes, enhanced intracellular ROS and sensitized mammospheres to taxol, and reduced the anchorage-independent growth. These results suggest that mammospheres rely on abnormal up-regulation of Nrf2 to maintain low intracellular ROS levels. Nrf2 inhibitors, such as brusatol, have the potential to be developed into novel adjuvant chemotherapeutic drug combinations in order to combat refractory tumor initiating CSCs.

Original languageEnglish (US)
Pages (from-to)1494-1502
Number of pages9
JournalMolecular Carcinogenesis
Volume54
Issue number11
DOIs
StatePublished - Nov 2015

Fingerprint

NF-E2-Related Factor 2
Oxidative Stress
Breast Neoplasms
Neoplastic Stem Cells
Therapeutics
Paclitaxel
Antioxidant Response Elements
Genes
Drug Combinations
Growth
Tumor Cell Line
Oxidation-Reduction
Neoplasms
Homeostasis
Transcription Factors
Up-Regulation

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

Wu, Tongde ; Harder, Bryan G. ; Wong, Pak K. ; Lang, Julie E. ; Zhang, Donna D. / Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?. In: Molecular Carcinogenesis. 2015 ; Vol. 54, No. 11. pp. 1494-1502.
@article{7e8d4b4036c54ce8b91012227063dae3,
title = "Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?",
abstract = "Mammosphere culture of breast cancer cell lines is an important approach used for enrichment of cancer stem cells (CSCs), which exhibit high tumorigenicity and chemoresistance features. Evidence shows that CSCs maintain lower ROS levels due to elevated expression of ROS-scavenging molecules and antioxidative enzymes, which favors the survival of the CSCs and their chemoresistance. The transcription factor NF-E2-related factor 2 (Nrf2) has emerged as the master regulator of cellular redox homeostasis, by up-regulating antioxidant response element (ARE)-bearing genes products. Although Nrf2 has long-term been regarded as a beneficial defense mechanism, accumulating studies have revealed the {"}dark side{"} of Nrf2. High constitutive levels of Nrf2 was observed in many types of tumors and cancer cell lines promoting their resistance to chemotherapeutics. In this study, we report a high expression of Nrf2 and its target genes in mammospheres compared to corresponding adherent cells. In MCF-7 and MDA-MB-231 mammmosphere cells, the Nrf2-mediated cellular protective response is significantly elevated which is associated with increased resistance to taxol and anchorage-independent growth. Brusatol, an inhibitor of the Nrf2 pathway, suppressed the protein level of Nrf2 and its target genes, enhanced intracellular ROS and sensitized mammospheres to taxol, and reduced the anchorage-independent growth. These results suggest that mammospheres rely on abnormal up-regulation of Nrf2 to maintain low intracellular ROS levels. Nrf2 inhibitors, such as brusatol, have the potential to be developed into novel adjuvant chemotherapeutic drug combinations in order to combat refractory tumor initiating CSCs.",
author = "Tongde Wu and Harder, {Bryan G.} and Wong, {Pak K.} and Lang, {Julie E.} and Zhang, {Donna D.}",
year = "2015",
month = "11",
doi = "10.1002/mc.22202",
language = "English (US)",
volume = "54",
pages = "1494--1502",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "11",

}

Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy? / Wu, Tongde; Harder, Bryan G.; Wong, Pak K.; Lang, Julie E.; Zhang, Donna D.

In: Molecular Carcinogenesis, Vol. 54, No. 11, 11.2015, p. 1494-1502.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?

AU - Wu, Tongde

AU - Harder, Bryan G.

AU - Wong, Pak K.

AU - Lang, Julie E.

AU - Zhang, Donna D.

PY - 2015/11

Y1 - 2015/11

N2 - Mammosphere culture of breast cancer cell lines is an important approach used for enrichment of cancer stem cells (CSCs), which exhibit high tumorigenicity and chemoresistance features. Evidence shows that CSCs maintain lower ROS levels due to elevated expression of ROS-scavenging molecules and antioxidative enzymes, which favors the survival of the CSCs and their chemoresistance. The transcription factor NF-E2-related factor 2 (Nrf2) has emerged as the master regulator of cellular redox homeostasis, by up-regulating antioxidant response element (ARE)-bearing genes products. Although Nrf2 has long-term been regarded as a beneficial defense mechanism, accumulating studies have revealed the "dark side" of Nrf2. High constitutive levels of Nrf2 was observed in many types of tumors and cancer cell lines promoting their resistance to chemotherapeutics. In this study, we report a high expression of Nrf2 and its target genes in mammospheres compared to corresponding adherent cells. In MCF-7 and MDA-MB-231 mammmosphere cells, the Nrf2-mediated cellular protective response is significantly elevated which is associated with increased resistance to taxol and anchorage-independent growth. Brusatol, an inhibitor of the Nrf2 pathway, suppressed the protein level of Nrf2 and its target genes, enhanced intracellular ROS and sensitized mammospheres to taxol, and reduced the anchorage-independent growth. These results suggest that mammospheres rely on abnormal up-regulation of Nrf2 to maintain low intracellular ROS levels. Nrf2 inhibitors, such as brusatol, have the potential to be developed into novel adjuvant chemotherapeutic drug combinations in order to combat refractory tumor initiating CSCs.

AB - Mammosphere culture of breast cancer cell lines is an important approach used for enrichment of cancer stem cells (CSCs), which exhibit high tumorigenicity and chemoresistance features. Evidence shows that CSCs maintain lower ROS levels due to elevated expression of ROS-scavenging molecules and antioxidative enzymes, which favors the survival of the CSCs and their chemoresistance. The transcription factor NF-E2-related factor 2 (Nrf2) has emerged as the master regulator of cellular redox homeostasis, by up-regulating antioxidant response element (ARE)-bearing genes products. Although Nrf2 has long-term been regarded as a beneficial defense mechanism, accumulating studies have revealed the "dark side" of Nrf2. High constitutive levels of Nrf2 was observed in many types of tumors and cancer cell lines promoting their resistance to chemotherapeutics. In this study, we report a high expression of Nrf2 and its target genes in mammospheres compared to corresponding adherent cells. In MCF-7 and MDA-MB-231 mammmosphere cells, the Nrf2-mediated cellular protective response is significantly elevated which is associated with increased resistance to taxol and anchorage-independent growth. Brusatol, an inhibitor of the Nrf2 pathway, suppressed the protein level of Nrf2 and its target genes, enhanced intracellular ROS and sensitized mammospheres to taxol, and reduced the anchorage-independent growth. These results suggest that mammospheres rely on abnormal up-regulation of Nrf2 to maintain low intracellular ROS levels. Nrf2 inhibitors, such as brusatol, have the potential to be developed into novel adjuvant chemotherapeutic drug combinations in order to combat refractory tumor initiating CSCs.

UR - http://www.scopus.com/inward/record.url?scp=84945195574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945195574&partnerID=8YFLogxK

U2 - 10.1002/mc.22202

DO - 10.1002/mc.22202

M3 - Article

C2 - 25154499

AN - SCOPUS:84945195574

VL - 54

SP - 1494

EP - 1502

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 11

ER -